Universal Influenza Vaccines, a Dream to Be Realized Soon

Due to frequent viral antigenic change, current influenza vaccines need to be re-formulated annually to match the circulating strains for battling seasonal influenza epidemics. These vaccines are also ineffective in preventing occasional outbreaks of new influenza pandemic viruses. All these challe...

Full description

Bibliographic Details
Main Authors: Han Zhang, Li Wang, Richard W. Compans, Bao-Zhong Wang
Format: Article
Language:English
Published: MDPI AG 2014-04-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/6/5/1974
id doaj-19c9d74046504e2399598158d2759719
record_format Article
spelling doaj-19c9d74046504e2399598158d27597192020-11-24T22:39:00ZengMDPI AGViruses1999-49152014-04-01651974199110.3390/v6051974v6051974Universal Influenza Vaccines, a Dream to Be Realized SoonHan Zhang0Li Wang1Richard W. Compans2Bao-Zhong Wang3Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USADepartment of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USADepartment of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USADepartment of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USADue to frequent viral antigenic change, current influenza vaccines need to be re-formulated annually to match the circulating strains for battling seasonal influenza epidemics. These vaccines are also ineffective in preventing occasional outbreaks of new influenza pandemic viruses. All these challenges call for the development of universal influenza vaccines capable of conferring broad cross-protection against multiple subtypes of influenza A viruses. Facilitated by the advancement in modern molecular biology, delicate antigen design becomes one of the most effective factors for fulfilling such goals. Conserved epitopes residing in virus surface proteins including influenza matrix protein 2 and the stalk domain of the hemagglutinin draw general interest for improved antigen design. The present review summarizes the recent progress in such endeavors and also covers the encouraging progress in integrated antigen/adjuvant delivery and controlled release technology that facilitate the development of an affordable universal influenza vaccine.http://www.mdpi.com/1999-4915/6/5/1974influenzacross protectionuniversal influenza vaccine
collection DOAJ
language English
format Article
sources DOAJ
author Han Zhang
Li Wang
Richard W. Compans
Bao-Zhong Wang
spellingShingle Han Zhang
Li Wang
Richard W. Compans
Bao-Zhong Wang
Universal Influenza Vaccines, a Dream to Be Realized Soon
Viruses
influenza
cross protection
universal influenza vaccine
author_facet Han Zhang
Li Wang
Richard W. Compans
Bao-Zhong Wang
author_sort Han Zhang
title Universal Influenza Vaccines, a Dream to Be Realized Soon
title_short Universal Influenza Vaccines, a Dream to Be Realized Soon
title_full Universal Influenza Vaccines, a Dream to Be Realized Soon
title_fullStr Universal Influenza Vaccines, a Dream to Be Realized Soon
title_full_unstemmed Universal Influenza Vaccines, a Dream to Be Realized Soon
title_sort universal influenza vaccines, a dream to be realized soon
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2014-04-01
description Due to frequent viral antigenic change, current influenza vaccines need to be re-formulated annually to match the circulating strains for battling seasonal influenza epidemics. These vaccines are also ineffective in preventing occasional outbreaks of new influenza pandemic viruses. All these challenges call for the development of universal influenza vaccines capable of conferring broad cross-protection against multiple subtypes of influenza A viruses. Facilitated by the advancement in modern molecular biology, delicate antigen design becomes one of the most effective factors for fulfilling such goals. Conserved epitopes residing in virus surface proteins including influenza matrix protein 2 and the stalk domain of the hemagglutinin draw general interest for improved antigen design. The present review summarizes the recent progress in such endeavors and also covers the encouraging progress in integrated antigen/adjuvant delivery and controlled release technology that facilitate the development of an affordable universal influenza vaccine.
topic influenza
cross protection
universal influenza vaccine
url http://www.mdpi.com/1999-4915/6/5/1974
work_keys_str_mv AT hanzhang universalinfluenzavaccinesadreamtoberealizedsoon
AT liwang universalinfluenzavaccinesadreamtoberealizedsoon
AT richardwcompans universalinfluenzavaccinesadreamtoberealizedsoon
AT baozhongwang universalinfluenzavaccinesadreamtoberealizedsoon
_version_ 1725710739363069952